A Single-centre, Open-label, Randomised, Single-dose Study to Evaluate the Effect of Pre- and Post-dose Meal Timings on the Pharmacokinetic Properties of Inno8 in Healthy Participants
Latest Information Update: 05 Jan 2026
At a glance
- Drugs Inno-8 (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
Most Recent Events
- 31 Dec 2025 Status changed from not yet recruiting to recruiting.
- 02 Dec 2025 New trial record